K
Koning
3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
About Koning
Koning Health is a medical technology company specializing in advanced breast imaging solutions. The company has developed the Koning Breast Computed Tomography (KBCT), a cutting-edge imaging device that produces high contrast, real 3D images of the breast with exceptional spatial resolution. Unlike traditional mammograms, the KBCT offers a rapid 10-second exposure without painful compression, making it a more comfortable and efficient option for patients. Koning Health serves healthcare providers and clinicians worldwide, aiming to improve early disease detection, diagnosis, and treatment outcomes. The company operates in the medical imaging market and generates revenue through the sale and distribution of its imaging devices. Koning Health's business model focuses on leveraging its patented cone beam CT technology, which has been in development for over two decades, to offer a superior alternative to traditional imaging methods. The company has received multiple awards, including the 2016 Frost and Sullivan New Innovation Award in Breast Imaging, and holds over 80 patents globally. Koning Health's mission is to revolutionize breast imaging and improve survival rates and outcomes for millions of patients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2002
- Headquarters
- Norcross, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 44.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Image Recognition, Oncology, Spinout, DT and LS
- Technology
- Artificial Intelligence, 3D Technology, Big Data, Deep Tech, Machine Learning, Computer Vision, Recognition Technology
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | May 2025 | — | — | Undisclosed | ↗ |
| SERIES B✓Equity / VC | Dec 2014 | $12M | $48M | Beijing Dingxin Capital | — |
Growth signals
Latest recorded traffic for Koning is 11K monthly website visits, up 44.7% over the last three months. Koning's team grew 2.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Screenpoint MedicalSmart AI for early breast cancer detection |
Nijmegen, Netherlands | Operational | 85 | $49M | $140M |
 AIgnosticsAI-powered pathology for precision medicine and drug development |
Berlin, Germany | Operational | |||
 TechsoMedReal time Predictive visualization of true ablation damage |
Rehovot, Israel | Operational | |||
 Vasolux MicrosystemsOptically based medical devices |
Elyria, United States | Closed | |||
 TechcyteUsing deep machine learning and digital pathology to automate microscopy tests for human & veterinary medicine & air quality control |
Orem, United States | Operational | |||
 Perceive3dDevelops computer-aided orthopaedic surgery systems |
Coimbra, Portugal | Operational | |||
 IntelligynBuilding the future of gynecological diagnostics with advanced AI technology for accurate and equal care, everywhere |
Stockholms kommun, Sweden | Operational | |||
 AlgoSurgAI-powered platform for automated surgical planning and guidance |
Wilmington, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Excell Partners
Series A2 investors entered at this stage
- SCSansar Capital
- BCBeijing Dingxin Capital
Other known investors4 additional known investors
University of Rochester
Cacao Capital
Knockout Capital
Nextcorps
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Koning on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Koning’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.